We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
US-based medical technology firm Axonics Modulation Technologies has secured the US Food & Drug Administration (FDA) approval of its new wireless patient Remote Control with SmartMRI technology. The
Surgical Information Sciences (SIS), a medical device company focused on improved visualization of targets for deep brain stimulation (DBS) surgery, announced completion of requirements to apply CE Mark
ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that the ZOLL AED 3® defibrillator received premarket approval (PMA)
Teleflex Incorporated, a US-based medical technologies provider, has enrolled the first patient in a clinical study that will evaluate performance of Teleflex coronary guidewires and specialty catheters. The
ReddyPort, a US-based medical technology company has received Conformité Européene (CE) Mark approval for ReddyPort Elbow, its non-invasive ventilation (NIV) product. The CE mark approval enables the company
Zebra Medical Vision (https://www.zebra-med.com/), the deep-learning medical imaging analytics company, has partnered with Apollo Hospitals Group to deploy its software to assist Apollo Hospitals doctors with efficient and
Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology innovation company, today announces that it has been proudly supporting the ongoing NHS COVID-19 response for
Abiomed received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for Impella RP to treat patients suffering from Covid-19 related right heart failure or decompensation,
Boston Scientific has launched its DIRECTSENSE Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures in the US. The new monitoring
Bruker Corporation (Nasdaq: BRKR) today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial MALDI-2 post-ionization (PI) source, which